New York A 9535: Establishes a generic drug research and development laboratory and production facility and the empire state biosimilar insulin initiative

Status: REFERRED TO HEALTH (as of 2024-03-20)

State: New York · Session: 2023-2024 · Bill: A 9535

Sponsors: Phil Steck

View New York A 9535 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.